SLNO — Soleno Therapeutics Share News
0.000.00%
Last trade - 00:00- $2.76bn
- $2.56bn
- $190.41m
Brief: Scorpion Capital Says We Are Short Soleno Therapeutics
Live Markets: Prader-Willi drug sparks Wall Street interest in multi-billion dollar market, Leerink says
Soleno Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Soleno Therapeutics Q2 net loss $4.7 mln
U.S. RESEARCH ROUNDUP-Core Scientific, Phillips 66, Starbucks
U.S. STOCKS ON THE MOVE-Tesla, AbbVie, McDonald's
U.S. STOCKS ON THE MOVE-Copper miners, AMD, DallasNews
Soleno Therapeutics falls after $200 million stock sale priced
U.S. STOCKS ON THE MOVE-Huntington Ingalls, Nucor, Estee Lauder
U.S. STOCKS ON THE MOVE-Gold miners, MP Materials, Delta
Brief: Soleno Therapeutics Announces Proposed $200 Million Public Offering Of Common Stock
Brief: Soleno Therapeutics Announces Preliminary Financial And Operational Results for Q2
Soleno Therapeutics falls on planned $200 million stock sale
U.S. STOCKS ON THE MOVE-DoorDash, Accenture, KB Home
U.S. STOCKS ON THE MOVE-Fiserv, Eli Lilly, Nuclear stocks
TD Cowen starts coverage on Soleno Therapeutics with "buy" following FDA approval of first PWS hunger treatment
Soleno Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Rigel Pharma, Concentrix, Avis Budget
Soleno jumps as analysts say US nod for rare disease drug transforms treatment options (updated)